VIATRIS INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
VIATRIS INC. (VTRS) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $400.00K, a 0.00% change year-over-year.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $56.60M, a 84.97% increase year-over-year.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-31 was -$1.90M, a 2000.00% decline year-over-year.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $700.00K, a 30.00% decline year-over-year.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $29.80M, a 43.02% decline from fiscal 2024.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $52.30M, a 100.38% increase from fiscal 2023.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $26.10M, a 125.00% increase from fiscal 2022.
- VIATRIS INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $11.60M, a 16.55% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-06 | $57.00M 10-Q · filed 2026-08-06 | $55.10M derived: sum of 3 quarters · filed 2026-08-06 | $55.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $56.60M 10-Q · filed 2026-05-07 | $54.70M derived: sum of 2 quarters · filed 2026-05-07 | $55.40M derived: sum of 3 quarters · filed 2026-05-07 | $55.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.20M derived: sum of 2 quarters · filed 2026-02-26 | -$800.00K derived: sum of 3 quarters · filed 2026-08-06 | $29.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-06 | $1.10M derived: sum of 2 quarters · filed 2026-08-06 | $31.70M 10-Q · filed 2025-11-06 | $31.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-06 | $31.00M 10-Q · filed 2026-08-06 | $31.10M derived: sum of 3 quarters · filed 2026-08-06 | $32.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $30.60M 10-Q · filed 2026-05-07 | $30.70M derived: sum of 2 quarters · filed 2026-05-07 | $31.70M derived: sum of 3 quarters · filed 2026-05-07 | $54.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.10M derived: sum of 2 quarters · filed 2026-02-26 | $23.50M derived: sum of 3 quarters · filed 2026-02-26 | $52.30M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-06 | $23.40M derived: sum of 2 quarters · filed 2025-11-06 | $52.20M 10-Q · filed 2025-11-06 | $56.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $22.40M 10-Q · filed 2025-08-07 | $51.20M 10-Q · filed 2025-08-07 | $55.10M derived: sum of 3 quarters · filed 2026-02-26 | $57.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $28.80M 10-Q · filed 2025-05-08 | $32.70M derived: sum of 2 quarters · filed 2026-02-26 | $35.20M derived: sum of 3 quarters · filed 2026-02-26 | $35.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.40M derived: sum of 2 quarters · filed 2026-02-26 | $6.70M derived: sum of 3 quarters · filed 2026-02-26 | $26.10M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.50M 10-Q · filed 2024-11-07 | $2.80M derived: sum of 2 quarters · filed 2024-11-07 | $22.20M 10-Q · filed 2024-11-07 | $25.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-08 | $19.70M 10-Q · filed 2024-08-08 | $22.70M derived: sum of 3 quarters · filed 2025-02-27 | $22.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $19.40M 10-Q · filed 2024-05-09 | $22.40M derived: sum of 2 quarters · filed 2025-02-27 | $22.60M derived: sum of 3 quarters · filed 2025-02-27 | $22.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.20M derived: sum of 2 quarters · filed 2025-02-27 | $2.70M derived: sum of 3 quarters · filed 2025-02-27 | $11.60M 10-K · filed 2025-02-27 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-07 | -$300.00K derived: sum of 2 quarters · filed 2023-08-07 | $8.60M 10-Q · filed 2023-11-08 | $9.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $8.80M 10-Q · filed 2023-08-07 | $9.30M derived: sum of 3 quarters · filed 2024-02-28 | $10.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $9.30M 10-Q · filed 2023-05-08 | $9.80M derived: sum of 2 quarters · filed 2024-02-28 | $10.60M derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.30M derived: sum of 2 quarters · filed 2024-02-28 | $13.90M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $800.00K 10-Q · filed 2022-11-07 | $13.40M 10-Q · filed 2022-11-07 | ||
| 2020-12-31 | $6.30M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |